There is an overwhelming expression of the CEACAM1-L isoform on melanoma cells [45, 82], and elevated serum CEACAM1 levels were found to positively correlate with decreased patient's survival, failure to respond to immunotherapy, and decreased efficacy of autologous vaccination [10, 83, 84]. The gene discussed is CEACAM1; the disease is melanoma.